Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Mesothelioma”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Large-scale testing (Phase 3)Study completedNCT00004920
What this trial is testing

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 256
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Ended earlyNCT01861301
What this trial is testing

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Epithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00020124
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00030745
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 61
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Large-scale testing (Phase 3)Active Not RecruitingNCT06097728
What this trial is testing

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Who this might be right for
Unresectable Pleural Mesothelioma
AstraZeneca 863
Large-scale testing (Phase 3)Study completedNCT03610360
What this trial is testing

DENdritic Cell Immunotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Amphera BV 176
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Ended earlyNCT04158141
What this trial is testing

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Epithelioid MesotheliomaStage I Pleural Malignant Mesothelioma AJCC v8+4 more
NRG Oncology 16
Large-scale testing (Phase 3)Study completedNCT03762018
What this trial is testing

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 400
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Early research (Phase 1)Active Not RecruitingNCT03228537
What this trial is testing

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaStage I Pleural Diffuse Malignant Mesothelioma AJCC v7+4 more
National Cancer Institute (NCI) 28
Next Page